BREONY STODDARD: Open Payments
NPI 1578711057 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 35 payments from 15 companies in 2025. Trend: 2023 $329 · 2024 $117 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $140 |
| Amgen Inc. | 5 | $89 |
| Astellas Pharma US Inc | 3 | $63 |
| Lilly USA, LLC | 3 | $47 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Novo Nordisk Inc | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Life Molecular Imaging Ltd | 1 | $26 |
Products named: EVENITY, Veozah, UBRELVY, VRAYLAR, INSPIRE, QULIPTA, CAPLYTA, MOUNJARO.
Industry payments across UT — which companies pay providers there.
